Pharmacological profile of brain-derived neurotrophic factor (BDNF) splice variant translation using a novel drug screening assay b

Journal of Biological Chemistry

Volumn 289, Issue 40, 2014, Pages 27702-27713

  Vaghi, Valentina ^a   Polacchini, Alessio ^a   Baj, Gabriele ^a   Pinheiro, Vera L M ^a   Vicario, Annalisa ^a   Tongiorgi, Enrico ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; MODULATION;

BRAIN-DERIVED NEUROTROPHIC FACTORS; HUMAN NEUROBLASTOMA; LUCIFERASE ASSAYS; NEURONAL DEVELOPMENT; PHARMACOLOGICAL PROFILES; PSYCHIATRIC DISORDERS; SPLICE VARIANTS; TRANSLATION REGULATION;

ENZYME INHIBITION;

3,5 DIHYDROXYPHENYLGLYCINE; ACETYLCHOLINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; DESIPRAMINE; DOPAMINE; MESSENGER RNA; MIRTAZAPINE; N METHYL DEXTRO ASPARTIC ACID; NORADRENALIN; POTASSIUM CHLORIDE; SEROTONIN; 3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANTIDEPRESSANT AGENT;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; EXON; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; NEUROBLASTOMA CELL; PROTEIN EXPRESSION; RNA TRANSLATION; TRANSLATION REGULATION; ALTERNATIVE RNA SPLICING; ANTAGONISTS AND INHIBITORS; GENETICS; METABOLISM; REPORTER GENE;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG EVALUATION, PRECLINICAL; GENES, REPORTER; HUMANS; PEPTIDE CHAIN ELONGATION, TRANSLATIONAL; RNA, MESSENGER;

EID: 84907495393     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.586719     Document Type: Article

References (60)

1. Cohen-Gory, S., Kidane, A. H., Shirkey, N. J., and Marshak, S. (2010) Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev. Neurobiol. 70, 271-288
2. Huang, E. J., and Reichardt, L. F. (2001) Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677-736
3. Altar, C. A., Vawter, M. P., and Ginsberg, S. D. (2009) Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology 34,18-54
4. Domenici, E., Willé, D. R., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I, Turck, C. W., Holsboer, F., Bullmore, E. T., Middleton, L., Merlo-Pich, E., Alexander, R. C., and Muglia, P. (2010) Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One 5, e9166
5. Autry, A. E., and Monteggia, L. M. (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64, 238-258
6. Castrén, E., Elgersma, Y., Maffei, L., and Hagerman, R. (2012) Treatment of neurodevelopmental disorders in adulthood. J Neurosci 32,14074-14079
7. Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., and Timmusk, T. (2007) Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85, 525-535
8. Pruunsild, P., Kazantseva, A., Aid, T., Palm, K., and Timmusk, T. (2007) Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90, 397-406
9. Pruunsild, P., Sepp, M., Orav, E., Koppel, I., and Timmusk, T. (2011) Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene. J. Neurosci. 31, 3295-3308
10. Dias, B. G., Banerjee, S. B., Duman, R. S., and Vaidya, V. A. (2003) Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45,553-563
11. Russo-Neustadt, A. A., Alejandre, H., Garcia, C.,Ivy, A.S., and Chen, M.J. (2004) Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, cital opram, and physical exercise. Neuropsychopharmacology 29, 2189 -2199
12. Yasuda, S., Liang, M. H., Marinova, Z., Yahyavi, A., and Chuang, D. M. (2009) The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol. Psychiatry 14, 51-59
13. Calabrese, F., Molteni, R., Maj, P. F., Cattaneo, A., Gennarelli, M., Racagni, G., and Riva, M. A. (2007) Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32, 2351-2359
14. Guillemot, F., Cerutti, I, Auffray, C., and Devignes, M. D. (2007) A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo. Transgenic Res. 16, 223-237
15. Koppel, I, Aid-Pavlidis, T., Jaanson, K., Sepp, M., Palm, K., and Timmusk, T. (2010) BAG transgenic mice reveal distal cis-regulatory elements governing BDNF gene expression. Genesis 48, 214-219
16. Koppel, I, Aid-Pavlidis, T., Jaanson, K., Sepp, M., Pruunsild, P., Palm, K.,and Timmusk, T. (2009) Tissue-specific and neural activity-regulated expression of human BDNF gene in BAG transgenic mice. BMC Neurosci. 10,68
17. Korecka, J. A., van Kesteren, R. E., Blaas, E., Spitzer, S. O., Kamstra, J. H., Smit, A. B., Swaab, D. F., Verhaagen, J., and Bossers, K. (2013) Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One 8, e63862
18. Martín-Montañez, E., Acevedo, M. J., López-Téllez, J. F., Duncan, R. S., Mateos, A. G., Pavíia, J., Koulen, P., and Khan, Z. U. (2010) Regulator of G-protein signaling 14 protein modulates Ca2+ influx through Cav1 channels. Neuroreport 21,1034-1039
19. Rogers, D. A., and Schor, N. F. (2013) Kidins220/ARMS is expressed in neuroblastoma tumors and stabilizes neurotrophic signaling in a human neuroblastoma cell line. Pediatr. Res. 74, 517-524
20. Deng, W., Wang, H., Rosenberg, P. A., Volpe, J. J., and Jensen, F. E. (2004) Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 101, 7751-7756
21. Wang, K. K., Nath, R., Posner, A., Raser, K. J., Buroker-Kilgore, M., Hajimohammadreza, I, Probert A. W., Jr., Marcoux, F. W., Ye, Q., Takano, E., Hatanaka, M., Maki, M., Caner, H., Collins, J. L., Fergus, A., Lee, K. S., Lunney, E. A., Hays, S. J., and Yuen, P. (1996) An a-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc. Natl. Acad. Sci. U.S.A. 93, 6687-6692
22. Ruiz, A., Alberdi, E., and Matute, C. (2014) CGP37157, an inhibitor of the mitochondrial Na+/Ca2+ exchanger, protects neurons from excitotoxicity by blocking voltage-gated Ca2+ channels. Cell Death Dis. 5, el 156
23. Jin, A. H., Vetter, I, Dutertre, S., Abraham, N., Emidio, N. B., Inserra, M., Murali, S. S., Christie, M. J., Alewood, P. F., and Lewis, R. J. (2014) MrIC, a novel α-conotoxin agonist in the presence of PNU at endogenous α7 nicotinic acetylcholine receptors. Biochemistry 53, 1-3
24. Allen, G. F., Ullah, Y., Hargreaves, I.P., Land, J. M., and Heales, S. J. (2013) Dopamine but not L-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson's and other dopamine deficiency states. Neurochem Int. 62, 684-694
25. Moussa, C. E., Wersinger, C., Tomita, Y., and Sidhu, A. (2004) Differential cytotoxicity of human wild type and mutant a-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Biochemistry 43,5539-5550
26. Oury, F., Yadav, V. K., Wang, Y., Zhou, B., Liu, X. S., Guo, X. E., Tecott, L. H., Schutz, G., Means, A. R., and Karsenty, G. (2010) CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons. Genes Dev. 24, 2330-2342
27. Donnici, L., Tiraboschi, E., Tardito, D., Musazzi, L., Racagni, G., and Popoli, M. (2008) Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells. BMC Neurosci. 9, 61
28. Fukuyama, K., Tanahashi, S., Hamaguchi, T., Nakagawa, M., Shiroyama, T., Motomura, E., and Okada, M. (2013) Differential mechanisms underlie the regulation of serotonergic transmission in the dorsal and median raphe nuclei by mirtazapine: a dual probe microdialysis study. Psychopharmacology 229, 617-626
29. Tongiorgi, E., Righi, M., and Cattaneo, A. (1997) Activity-dependent dendritic targeting of BDNF and TrkB mRNAs in hippocampal neurons.J. Neurosci. 17, 9492-9505
30. Tongiorgi, E., Armellin, M., Giulianini, P. G., Bregola, G., Zucchini, S., Paradiso, B., Steward, O., Cattaneo, A., and Simonato, M. (2004) Brainderived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis. J. Neurosci. 24,6842-6852
31. Lorenz, R., Bernhart, S. H., Höner Zu Siederdissen, C., Tafer, H., Flamm, C., Stadler, P. F., and Hofacker, I. L. (2011) ViennaRNA Package 2.0. Algorithms Mol. Biol. 6, 26
32. Doshi, K. J., Cannone, J. J., Cobaugh, C. W., and Gutell, R. R. (2004) Evaluation of the suitability of free-energy minimization using nearest-neighbor energy parameters for RNA secondary structure prediction. BMC Bioinformatics 5,105
33. Nakagawa, S., Niimura, Y., Gojobori, T., Tanaka, H., and Miura, K. (2008) Diversity of preferred nucleotide sequences around the translation initiation codon in eukaryote genomes. Nucleic Acids Res. 36, 861-871
34. Dunston, J. A., Hamlington, J. D., Zaveri, J., Sweeney, E., Sibbring, J., Tran, C., Malbroux, M., O'Neill, J. P., Mountford, R., and McIntosh, I. (2004) The human LMX1B gene: transcription unit, promoter, and pathogenic mutations. Genomics 84, 565-576
35. Kozak, M. (1999) Initiation of translation in prokaryotes and eukaryotes.Gene 234,187-208
36. Baj, G., Del Turco, D., Schlaudraff, J., Torelli, L, Deller, T., and Tongiorgi, E. (2013) Regulation of the spatial code for BDNF mRNA isoforms in the rat hippocampus following pilocarpine-treatment: a systematic analysis using laser microdissection and quantitative real-time PCR. Hippocampus 23,413-423
37. Tardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., and Popoli, M. (2006) Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol. Rev. 58, 115-134
38. Duman, R. S., and Monteggia, L. M. (2006) A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59,1116-1127
39. Castrén, E., Vöikar, V., and Rantamäki, T. (2007) Role of neurotrophic factors in depression. Curr. Opin Pharmacol. 7,18-21
40. Chiaruttini, C., Vicario, A., Li, Z., Baj, G., Braiuca, P., Wu, Y., Lee, F. S., Gardossi, L., Baraban, J. M., and Tongiorgi, E. (2009) Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation. Proc. Natl. Acad. Sci. U.S.A. 106, 16481-16486
41. Cattaneo, E., and Zuccato, C. (April 17, 2002) U. S. Patent 20050123922 A1
42. Heinrich, G., and Huynh, G. (November 30, 2003) U. S. Patent US7491910 B2
43. Tropea, D., Capsoni, S., Tongiorgi, E., Giannotta, S., Cattaneo, A., and Domenici, L. (2001) Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience. Eur.J. Neurosci. 13, 709-721
44. Lau, A. G., Irier, H. A., Gu, J., Ti an, D., Ku, L., Liu, G., Xia, M., Fritsch, B., Zheng, J. Q., Dingledine, R., Xu, B., Lu, B., and Feng, Y. (2010) Distinct 3UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF). Proc. Natl. Acad. Sci. U.S.A. 107,15945-15950
45. Barrett, L. W., Fletcher, S., and Wilton, S. D. (2012) Regulation of eukaryotic gene expression by the untranslated gene regions and other noncoding elements. Cell. Mol. Life Sci. 69, 3613-3634
46. Abuhatzira, L., Makedonski, K., Kaufman, Y., Razin, A., and Shemer, R. (2007) MeCP2 deficiency in the brain decreases BDNF levels by REST/ CoREST-mediated repression and increases TRKB production. Epigenetics 2,214-222
47. Bustos, G., Abarca, J., Bustos, V., Riquelme, E., Noriega, V., Moya, C., and Campusano, J. (2009) NMDA receptors mediate an early up-regulation ofbrain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease. J. Neurosci. Res. 87,2308-2318
48. Garzon, D., Yu, G., and Fahnestock, M. (2002) A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J. Neurochem.82,1058-1064
49. Tsukahara, T., Iihara, K., Hashimoto, N., Nishijima, T., and Taniguchi, T. (1998) Increases in levels of brain-derived neurotrophic factor mRNA and its promoters after transient forebrain ischemia in the rat brain. Neurochem. Int. 33, 201-207
50. Chiaruttini, C., Sonego, M., Baj, G., Simonato, M., and Tongiorgi, E. (2008) BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae. Mol. Cell. Neurosci. 37,11-19
51. Tongiorgi, E., and Baj, G. (2008) Functions and mechanisms of BDNF mRNA trafficking. Novartis Found. Symp. 289,136-147
52. Tongiorgi, E. (2008) Activity-dependent expression of brain-derived neurotrophic factor in dendrites: facts and open questions. Neurosci. Res. 61, 335-346
53. Baj, G., Leone, E., Chao, M. V., and Tongiorgi, E. (2011) Spatial segregation of BDNF transcripts enables BDNF to differentially shape distinct dendritic compartments. Proc. Natl. Acad. Sci. U.S.A. 108,16813-16818
54. Horch, H. W., and Katz, L. C. (2002) BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat. Neurosci. 5,1177-1184
55. Gulyás, A. L, Megías, M., Emri, Z., and Freund, T. F. (1999) Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J Neurosci. 19,10082-10097
56. Megias, M., Emri, Z., Freund, T. F., and Gulyás, A. I. (2001) Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience 102, 527-540
57. Sakata, K., Woo, N. H., Martinowich, K., Greene, J. S., Schloesser, R. J., Shen, L., and Lu, B. (2009) Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 106, 5942-5947
58. Yanow, S. K., Manseau, F., Hislop, J., Castellucci, V. F., and Sossin, W. S. (1998) Biochemical pathways by which serotonin regulates translation in the nervous system of Aplysia. J. Neurochem. 70, 572-583
59. Bowling, H., Zhang, G., Bhattacharya, A., Pérez-Cuesta, L. M., Deinhardt, K., Hoeffer, C. A., Neubert, T. A., Gan, W. B., Klann, E., and Chao, M. V. (2014) Antipsychotics activate mTORCl-dependent translation to enhance neuronal morphological complexity. Sci. Signal. 7, ra4
60. Gangarossa, G., and Valjent, E. (2012) Regulation of the ERK pathway in the dentate gyrus by in vivo dopamine D1 receptor stimulation requires glutamatergic transmission. Neuropharmacology 63,1107-1117